In 2023, Joseph K. Belanoff, M.D. earned $2.44M in total compensation at Corcept Therapeutics, including $1.10M salary and $1.32M bonus. Most recently sold 2,924 shares in Feb 2025. Currently holds stock worth $275.94M. Has donated $45.92M in stock to charitable causes. Has led Corcept Therapeutics for over 26 years.
Compensation History
Annual executive compensation data for Joseph K. Belanoff, M.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$2.44M
Salary
$1.10M
Bonus
$1.32M
Other
$22.50K
Salary
$1.10MBoard Justification
The compensation program aims to attract, motivate, and retain highly-qualified executive officers by offering competitive pay linked to performance and company goals.
Bonus
$1.32MBoard Justification
In March 2024, bonuses were paid to all employees, including named executive officers, based on the achievement of significant corporate goals in 2023.
Other Compensation
$22.50KBoard Justification
Other compensation includes contributions to the 401(k) Plan and other benefits.
Restricted Stock
Board Justification
No stock was vested in 2023 as only stock grants were mentioned, which are excluded from total calculations.
Performance Metrics
Performance metrics include revenue growth, successful completion of clinical trials, and advancements in clinical development programs.
Joseph K. Belanoff, M.D.
Founder and CEO of Corcept Therapeutics
Education
B.A. from Amherst College and M.D. from Columbia University’s College of Physicians & Surgeons.
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
January 1, 1957 - 68 years ago
CEO of Corcept Therapeutics for
26 years 11 months (Jan 1999 - Present)
Previous Experience
Co-founder of the Company and has served as a member of the Board and as the Company’s Chief Executive Officer since 1999. Currently a clinical faculty member at Stanford University.
Holdings
Track Joseph K. Belanoff, M.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$25.11M
$25.11M
1,772,173 CORT shares
What if they kept their stock?
If Joseph K. Belanoff, M.D. didn't sell their stock, today they would have:
Extra CORT1,772,173 shares worth $150.90M.
This is 500.99% and $125.79M more than what they got when they sold the stock.
Charitable Transactions
539,228 shares
CORT
Recent Charitable Transactions
539,228 shares
CORT
Dec 31, 2024
Charity
Insider Trading
Joseph K. Belanoff, M.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$178.10K
CORT at $60.91/share
Feb 28, 2025
Sale
539,228 shares
CORT
Dec 31, 2024
Charity
$8.80M
CORT at $26.26/share
Jul 6, 2022
Sale
$4.13M
CORT at $19.01/share
Dec 12, 2018
Sale
$4.13M
CORT at $19.01/share
Dec 12, 2018
Sale
$4.50M
CORT at $9.00/share
Nov 10, 2016
Sale
$4.14M
CORT at $8.27/share
Nov 7, 2016
Sale
Rivals
Compare Joseph K. Belanoff, M.D. with competitor CEOs and industry peers.